Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7590343

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
156,456,000 JPY
647,576,000 JPY
125,150,000 JPY
Ordinary profit (loss)
-54,731,000 JPY
-243,472,000 JPY
-101,640,000 JPY
Net assets
1,309,411,000 JPY
1,368,348,000 JPY
1,518,542,000 JPY
Total assets
1,649,544,000 JPY
1,705,338,000 JPY
1,707,152,000 JPY
Basic earnings (loss) per share
-6.32
-27.78
-11.89
Diluted earnings per share
Equity-to-asset ratio
0.794 xbrli:pure
0.802 xbrli:pure
0.888 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.